Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | FDPS | P14324 | 3/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL896647 | 1.00 | LMNA (0.48) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL15159317 | 1.00 | LMNA (0.48) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL6324963 | 1.00 | LMNA (0.48) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL2872482 | 0.91 | LMNA (0.45) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL6327110 | 0.86 | LMNA (0.48) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL4937119 | 0.84 | LMNA (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL8342910 | 0.84 | LMNA (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL6332954 | 0.84 | LMNA (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL14760005 | 0.84 | LMNA (0.50) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL5574632 | 0.80 | LMNA (0.37) | LMNADNM1TSHRTHRBOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392488-B1 | FUNCTIONALIZED SILICA NANOPARTICLES FOR USE IN THIOLENE CURE 3D PRINTING | NISSAN CHEMICAL AMERICA CORP (US) | 2025-07-30 | — | — | EP | claimed |
| US-20120081778-A1 | PIGMENT-BASED INK | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2012-04-05 | — | — | US | claimed |
| US-20250326936-A1 | ARTICLES INCLUDING SURFACE COATINGS AND METHODS TO PRODUCE THEM | MAXTERIAL INC (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4392488-B1 | FUNCTIONALIZED SILICA NANOPARTICLES FOR USE IN THIOLENE CURE 3D PRINTING | NISSAN CHEMICAL AMERICA CORP (US) | 2025-07-30 | — | — | EP | disclosed |
| US-12173166-B2 | Articles including surface coatings and methods to produce them | MAXTERIAL, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-12032261-B2 | Privacy films for electronic displays | Hewlett-Packard Development Company, L.P . (US) | 2024-07-09 | — | — | US | disclosed |
| EP-4392488-A1 | FUNCTIONALIZED SILICA NANOPARTICLES FOR USE IN THIOLENE CURE 3D PRINTING | Nissan Chemical America Corporation (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3743464-B1 | ORGANIC-INORGANIC AEROGEL COMPOSITES, METHODS AND USES THEREOF | BRONX CREATIVE&DESIGN CENTRE PTE LTD (SG) | 2024-03-06 | — | — | EP | disclosed |
| US-20230295827-A1 | COATINGS AND COATED SURFACES INCLUDING LOW-SURFACE ENERGY INORGANIC PARTICLES | MAXTERIAL INC (US) | 2023-09-21 | — | — | US | disclosed |
| WO-2023028288-A1 | FUNCTIONALIZED SILICA NANOPARTICLES FOR USE IN THIOLENE CURE 3D PRINTING | Nissan Chemical America Corporation (US) | 2023-03-02 | — | — | WO | disclosed |
| US-11542621-B1 | Coatings and coated surfaces including low-surface energy inorganic particles | MAXTERIAL, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-20150065670-A1 | ASYMMETRIC BIFUNCTIONAL SILYL MONOMERS AND PARTICLES THEREOF AS PRODRUGS AND DELIVERY VEHICLES FOR PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-03-05 | — | — | US | disclosed |
| US-20150065670-A1 | ASYMMETRIC BIFUNCTIONAL SILYL MONOMERS AND PARTICLES THEREOF AS PRODRUGS AND DELIVERY VEHICLES FOR PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-03-05 | — | — | US | disclosed |
| US-20130203675-A1 | ASYMMETRIC BIOFUNCTIONAL SILYL MONOMERS AND PARTICLES THEREOF AS PRODRUGS AND DELIVERY VEHICLES FOR PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL AGENTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2013-08-08 | — | — | US | disclosed |
| US-20130203675-A1 | ASYMMETRIC BIOFUNCTIONAL SILYL MONOMERS AND PARTICLES THEREOF AS PRODRUGS AND DELIVERY VEHICLES FOR PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL AGENTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2013-08-08 | — | — | US | disclosed |
| US-8354160-B2 | Articles having durable hydrophobic surfaces | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-15 | — | — | US | disclosed |
| US-20120081778-A1 | PIGMENT-BASED INK | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2012-04-05 | — | — | US | disclosed |
| EP-2051821-A1 | ARTICLES HAVING DURABLE HYDROPHOBIC SURFACES | 3M Innovative Properties Company (US) | 2009-04-29 | — | — | EP | disclosed |
| US-20070298216-A1 | ARTICLES HAVING DURABLE HYDROPHOBIC SURFACES | 3M INNOVATIVE PROPERTIES COMPANY | 2007-12-27 | — | — | US | disclosed |
| WO-2007149617-A1 | ARTICLES HAVING DURABLE HYDROPHOBIC SURFACES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150065670-A1 | ASYMMETRIC BIFUNCTIONAL SILYL MONOMERS AND PARTICLES THEREOF AS PRODRUGS AND DELIVERY VEHICLES FOR PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL AGENTS | PAICS, BSG, ILK | LMNA 1041/4885DNM1 1360/4885TSHR 4326/4885 |
| US-20130203675-A1 | ASYMMETRIC BIOFUNCTIONAL SILYL MONOMERS AND PARTICLES THEREOF AS PRODRUGS AND DELIVERY VEHICLES FOR PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL AGENTS | PAICS, ILK, BSG | LMNA 882/4885DNM1 1171/4885TSHR 4468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.